; (2) develop a coordinated and integrated research and investment plan for meeting near-, mid-, and long-term challenges for achieving broad technical goals that build upon the Department’s investment in emerging biotechnologies research and development, commercial sector and global investments, and other United States Government investments in emerging biotechnologies fields; (3) not later than 180 days after the date of the enactment of this Act, develop and continuously update guidance, including classification guidance for defense-related emerging biotechnologies activities, and policies for restricting access to research to minimize the effects of loss of intellectual property in basic and applied emerging biotechnologies and information considered sensitive to the leadership of the United States in the field of emerging biotechnologies